RecallHawk

FIORICET WITH CODEINE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE)

LGM PHARMA

Summary

FDA approved FIORICET WITH CODEINE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE) by LGM PHARMA. ANDA (Generic) approval (REMS) on 2026-06-18. CAPSULE, ORAL.

Details

Source

Drug Approval

External ID

ANDA076560-13

Action Date

2026-06-18

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

FIORICET WITH CODEINE (generic: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE), CAPSULE, ORAL. Application: ANDA076560

Company

Context & Analysis

LGM PHARMA has 2 FDA actions in our database.

Frequently Asked Questions

How often does LGM PHARMA have FDA actions?

LGM PHARMA has 2 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA076560-13" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions